GHDGrowth Hormone Deficiency
GHDGood Hair Day
GHDGlobal Handwashing Day (October 15)
GHDGroundhog Day
GHDGood Humanitarian Donorship
GHDGlucose Dehydrogenase (enzyme)
GHDGutteridge Haskins and Davey
GHDGraduate Hall Director (university housing)
GHDGonadal Hyper Distension (fitness training device)
GHDGround Hound Detection Services, Inc. (Boynton Beach, FL)
GHDGrowth Hormone Disorder
GHDGlobal Help Desk
GHDGlute Hamstring Developer (Ballistix Fitness; South Africa)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
According to Coty, the addition of ghd's market-leading and high-performance lines of hair straighteners, hairdryers and other hairstyling appliances is expected to further strengthen what the company says is its worldwide leading position in the professional hair category, ghd, which stands for "Good Hair Day," has been expanding from its core salon channel into premium retail and e-commerce.
ghd, which stands for "Good Hair Day," is headquartered in London and has commercial operations in the United Kingdom, Australia, the United States, Germany, France, Spain, Italy and several other markets.
Coty said it would pay ghd's owner, Lion Capital LLP, approximately $510 million in cash, funded with a combination of cash on hand and available debt facilities.
Headquartered in London, GHD has commercial operations in the UK, Australia, the US, Germany, France, Spain, Italy and several other markets.
"The change of outlook reflects ghd's weak financial profile and our expectations that its leverage (as adjusted by Moody's) will remain well beyond what we previously anticipated over the foreseeable future" says Guillaume Leglise, Moody's lead analyst for ghd.
* Overall, the greatest unmet need in the GHD space is the issue with treatment adherence and compliance.
the characteristics of short-statured children (average age 5.1) without GHD were small submaxillary, short basis cranii length, normal anterior facial height and increased lower anterior facial height.
Biopharmaceutical company OPKO Health (NYSE:OPK) disclosed on Friday the completion of enrollment of growth hormone deficient (GHD) adults under its single pivotal Phase 3 trial of (hGH-CTP).
"This agreement strengthens Pfizer's commitment to rare diseases, and we are pleased to work with OPKO to help provide a potential next-generation therapy for patients with Adult and Pediatric Growth Hormone Deficiency," said Geno Germano, group president, Pfizer Global Innovative Pharma (GIP)."Long-acting growth hormone is the first innovation in the GHD space in 20 years."
From top: Mop Glisten Shine Drops, GHD Final Fix Spray and Remington Keratin Pro Straighteners
Dragon selected GHD after reviewing proposals from five competing consulting groups.